Skip to main content

Table 1 Demographic and clinical characteristics

From: Effectiveness, safety and tolerability of a complex homeopathic medicinal product in the prevention of recurrent acute upper respiratory tract infections in children: a multicenter, open, comparative, randomized, controlled clinical trial

Characteristics

Statistics

CalSuli-4-02 group N = 99

Control group N = 101

Age (months)

Mean ± SD

34.2 ± 20.1

35.8 ± 20.0

Median

34.0

34.0

P25 %–P75 %

13.0–50.0

18.0–50.0

Min–Max

5.0–72.0

6.0–73.0

Gender

   

 Boys / Girls

N

52 / 47

53 / 48

Number of acute URTIs (12 months prior to study start)

Mean ± SD

6.8 ± 2.1

6.7 ± 1.9

Median

6.0

6.0

P25 %–P75 %

6.0–8.0

6.0–7.6

Min–Max

3.0–12.0

3.3–12.0

  1. SD standard deviation, URTIs upper respiratory tract infections, ITT intention-to-treat analysis